Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?
BACKGROUND: In India, the Revised National Tuberculosis Control Programme (RNTCP) has adopted the strategy of examining two specimens during follow-up culture examinations to monitor the treatment response of multi-drug resistant tuberculosis (MDR-TB) patients. OBJECTIVES: To determine the increment...
Main Authors: | Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, Ranjani Ramachandran, Srinath Satyanarayana, Avi Bansal, Malik Parmar, Sarabjit Chadha, Sreenivas Nair, Ashok Kumar, Sven Gudmund Hinderaker, Mary Edginton, Puneet K Dewan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3459961?pdf=render |
Similar Items
-
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010.
by: Kuldeep Singh Sachdeva, et al.
Published: (2011-01-01) -
Sputum smear microscopy at two months into continuation-phase: should it be done in all patients with sputum smear-positive tuberculosis?
by: Mohit Padamchand Gandhi, et al.
Published: (2012-01-01) -
Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration.
by: Madhavi Pothukuchi, et al.
Published: (2011-01-01) -
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.
by: Sarabjit S Chadha, et al.
Published: (2011-01-01) -
Tobacco use among tuberculosis patients across 30 districts in India in 2013 and 2017
by: Karuna Sagili, et al.
Published: (2018-03-01)